Top Markets
#1 ADO Protocol ADO Protocol +335.18%
#2 GoPlus Security GoPlus Security +42.11%
#3 Starpower Starpower +31.42%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.15%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +17.94%
#7 Nockchain Nockchain +14.81%
#8 DMT-NAT DMT-NAT +14.09%
#9 Provenance Blockchain Provenance Blockchain +12.69%
#10 Euler Euler +12.61%
Coin of the day
ADO Protocol ADO Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Classifica tra le azioni #33300
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Prezzo delle azioni
$0.4264
Ultima sincronizzazione: 2022-09-14
Capitalizzazione di mercato
$7.93M
Variazione (1 giorno)
-16.44%
Variazione (1 anno)
0.00%
Paese
US
Scambia Caladrius Biosciences, Inc. (CLBS)

Categoria

Healthcare
Storico del prezzo dell'azione per Caladrius Biosciences, Inc. (CLBS)
Prezzo di chiusura più alto: $0.50 il 2022-09-01

Prezzo di chiusura più basso: $20.36 il 2015-06-01
Storico del prezzo dell'azione di Caladrius Biosciences, Inc. dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2022 -43.51%
2021 -42.36%
2020 -36.52%
2019 -44.38%
2018 26.20%
2017 2.72%
2016 -70.04%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $511.97 30.34%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $984.83 50.62%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.15%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.62 13.43%
BE